Choice Overload in Systemic Psoriasis Therapy

Systemic therapy of psoriasis in diabetic patients

Psoriasis is a chronic inflammatory skin disease affecting 2-3% of worldwide population. Moderate to severe psoriasis is frequently associated with metabolic disorders including diabetes, obesity, dyslipidaemia, metabolic syndrome and non-alcoholic fatty liver disease. In particular, the prevalence of diabetes in patients with psoriasis ranges from 5 to 54%. Most of the studies found that the p...

Therapy treatment options for psoriasis: topical and systemic

Psoriasis, a Systemic Disease?

It has long been recognized the epidemiological association of psoriasis, especially the most severe forms, with several diseases that share a common pathogenic substrate involving TNF-α and different target organs (arthritis and Crohn disease, for example), as well as an increased risk of coronary heart disease and occlusive cardiovascular disease. In the patient with severe psoriasis there is...

[Psoriasis, a systemic disease?].

It has long been recognized the epidemiological association of psoriasis, especially the most severe forms, with several diseases that share a common pathogenic substrate involving TNF-alpha and different target organs (arthritis and Crohn's disease, for example), as well as an increased risk of coronary heart disease and occlusive cardiovascular disease. In the patient with severe psoriasis th...

Choice Overload and Simplicity Seeking

In settings such as investing for retirement or choosing a drug plan, individuals face a staggering number of options. In this paper, we analyze how an abundance of options influences which alternative is selected. We present both laboratory experiments and field data that confirm our theoretical prediction: larger choice sets induce a stronger preference for simple, easy-to-understand options....